Literature DB >> 18040791

Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.

Thomas W Klein1, Guy A Cabral.   

Abstract

The study of marijuana cannabinoid biology has led to many important discoveries in neuroscience and immunology. These studies have uncovered a new physiological system, the endocannabinoid system, which operates in the regulation of not only brain function but also the regulation of the immune system. Studies examining the effect of cannabinoid-based drugs on immunity have shown that many cellular and cytokine mechanisms are suppressed by these agents leading to the hypothesis that these drugs may be of value in the management of chronic inflammatory diseases. In this report, we review current information on cannabinoid ligand and receptor biology, mechanisms involved in immune suppression by cannabinoids with emphasis on antigen-presenting cells, and preclinical and clinical models analyzing the therapeutic potential of cannabinoid-based drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18040791     DOI: 10.1007/s11481-005-9007-x

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   7.285


  128 in total

1.  Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status.

Authors:  Nazik Rayman; King H Lam; Jon D Laman; Peter J Simons; Bob Löwenberg; Pieter Sonneveld; Ruud Delwel
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells.

Authors:  R A Puffenbarger; A C Boothe; G A Cabral
Journal:  Glia       Date:  2000-01-01       Impact factor: 7.452

Review 3.  The endocannabinoid signaling system: pharmacological and therapeutic aspects.

Authors:  Christopher J Fowler; Sandra Holt; Olov Nilsson; Kent-Olov Jonsson; Gunnar Tiger; Stig O P Jacobsson
Journal:  Pharmacol Biochem Behav       Date:  2005-06       Impact factor: 3.533

4.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

5.  2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

Authors:  L Hanus; S Abu-Lafi; E Fride; A Breuer; Z Vogel; D E Shalev; I Kustanovich; R Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

6.  Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility.

Authors:  M Maccarrone; H Valensise; M Bari; N Lazzarin; C Romanini; A Finazzi-Agrò
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

7.  Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.

Authors:  Amy C Porter; John-Michael Sauer; Michael D Knierman; Gerald W Becker; Michael J Berna; Jingqi Bao; George G Nomikos; Petra Carter; Frank P Bymaster; Andrea Baker Leese; Christian C Felder
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

8.  Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.

Authors:  L X Zhu; S Sharma; M Stolina; B Gardner; M D Roth; D P Tashkin; S M Dubinett
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

9.  Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor.

Authors:  Y Daaka; W Zhu; H Friedman; T W Klein
Journal:  DNA Cell Biol       Date:  1997-03       Impact factor: 3.311

10.  Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities.

Authors:  S H Burstein; C A Audette; A Breuer; W A Devane; S Colodner; S A Doyle; R Mechoulam
Journal:  J Med Chem       Date:  1992-08-21       Impact factor: 7.446

View more
  62 in total

Review 1.  Immunology as it pertains to drugs of abuse, AIDS and the neuroimmune axis: mediators and traffic.

Authors:  Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2010-10-19       Impact factor: 4.147

Review 2.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

Review 3.  Opioid receptors and signaling on cells from the immune system.

Authors:  Jean M Bidlack; Maxim Khimich; Amy L Parkhill; Sarah Sumagin; Baoyong Sun; Christopher M Tipton
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-08       Impact factor: 4.147

4.  Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.

Authors:  Nicholas T Vozoris; Zhan Yao; Ping Li; Peter C Austin; Anne L Stephenson; Sudeep S Gill; Denis E O'Donnell; Andrea S Gershon; Paula A Rochon
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

Review 5.  Cannabis, the pregnant woman and her child: weeding out the myths.

Authors:  S C Jaques; A Kingsbury; P Henshcke; C Chomchai; S Clews; J Falconer; M E Abdel-Latif; J M Feller; J L Oei
Journal:  J Perinatol       Date:  2014-01-23       Impact factor: 2.521

6.  Determinants of pulse wave velocity trajectories from youth to young adulthood: the Georgia Stress and Heart Study.

Authors:  Xiaohua Liang; Shaoyong Su; Guang Hao; Harold Snieder; Frank Treiber; Gaston Kapuku; Xiaoling Wang
Journal:  J Hypertens       Date:  2019-03       Impact factor: 4.844

7.  Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies.

Authors:  Tarek Taha; David Meiri; Samira Talhamy; Mira Wollner; Avivit Peer; Gil Bar-Sela
Journal:  Oncologist       Date:  2019-01-22

8.  Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Authors:  Dario Siniscalco; Anna Sapone; Catia Giordano; Alessandra Cirillo; Laura de Magistris; Francesco Rossi; Alessio Fasano; James Jeffrey Bradstreet; Sabatino Maione; Nicola Antonucci
Journal:  J Autism Dev Disord       Date:  2013-11

9.  Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors.

Authors:  Maheswari Rajasekaran; Lisa K Brents; Lirit N Franks; Jeffery H Moran; Paul L Prather
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-26       Impact factor: 4.219

Review 10.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.